Thelial Technologies engages in targeted carcinoma drug discovery and development.
Business Model:
Revenue: $0
Employees: 1-10
Address: Rua Rodrigues Faria, 103
City: Lisbon
State: lisbon district
Zip: 1300-501
Country: PT
Thelial is a targeted carcinoma drug discovery and development company. theLiTE™ (Thelial – Live Targeted Epithelia) is our proprietary targeted carcinoma drug discovery platform technology; screening a library of more than 1200 drug candidates we have discovered six carcinoma targeted drug candidates, validating theLiTE™. To prove the concept we combine theLiTE™ with a powerful approach to advance novel therapies: drug repositioning, identifying new roles for known drug compounds. In parallel we develop a novel treatment class, targeting actin in cancer.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 12/2016 | Grant | 1 | $53.3k |
EASME - EU Executive Agency for SMEs EASME - EU Executive Agency for SMEs |
12/2010 | Seed Round | 1 | $394.1k |
Portugal Ventures Portugal Ventures |
7/2009 | Angel Round | 1 | $84.9k |
Biocant Ventures Biocant Ventures |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|